Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Nuclear Medicine and Molecular Imaging
>
2015
>
35
Volume:
35
1. Targeting islet cell using 18F-Fallypride: in vitro and histoautoradiography study
Page:131—134
2. Optimal preparation procedure and quality evaluation of the superparamagnetic iron oxide coated by dextran
Page:139—144
3. Clinical significance of negative thyroglobulin and positive diagnostic whole body scan in patients with differentiated thyroid carcinoma who underwent thyroid remnant ablation
Page:154—156
4. Experimental study on multiple tracers PET/CT in the differentiation of C6 glioma from different inflammation
Page:396—402
5. Application of multimodal imaging in stem cell research
Page:407—409
6. Application of 18F-FMISO for tumor hypoxia imaging
Page:410—413
7. CT and 18F-FDG PET/CT features of pulmonary sclerosing hemangioma
Page:251—253
8. Curative efficacy and influential factors of 131I treatment for lung metastases from differentiated thyroid carcinoma
Page:258—261
9. Progress on the clinical research of fluoro-3(2(S)-2-azetidinylmethoxy) pyridine and Iodo-3-(2(S)-azetidinylmethoxy) pyridine
Page:322—325
10. Progress of 99Tcm-labeled glucose and its analogs in tumor imaging
Page:319—321
11. The diagnostic value of 18F-FDG PET/CT in differentiated thyroid carcinoma
Page:315—318
12. Automated synthesis and quality analysis of 18F-FMISO based on CFN-MPS-100 module
Page:303—305
13. In vitro study of type Ⅰ intron-mediated dual reporter gene imaging for carcinoembryonic antigen
Page:298—302
14. Diagnostic value of 18F-FDG PET/CT for differentiating multiple myeloma from bone metastases with undetermined origin
Page:284—288
15. Diagnostic value of SPECT/CT for lumbar spondylolysis
Page:280—283
16. Association between iodine intake and treatment outcomes of radioiodine remnant ablation in patients with papillary thyroid cancer
Page:268—271
17. Effect of taking L-T4 in bedtime vs morning on changes of serum thyroid hormone concentration in patients with hypothyroidism
Page:265—267
18. Comparison of 13N-NH3 and 18F-FDG PET/CT in the evaluation of gliomas
Page:374—378
19. Synthesis and preliminary evaluation of 18F-AIF-NOTA-G-TMTP1 for PET imaging on nude mice bearing high-metastatic potential hepatoma cells
Page:351—354
20. Monitoring the migration of bone marrow derived mesenchymal stem cells to intracranial glioma by sodium iodide sympoter
Page:346—350
21. Differential diagnosis of rat C6 glioma and inflammation with 18F-FDG, 11C-MET and 11C-CHO PET/CT imaging and their correlations with HIF-1α and VEGF
Page:340—345
22. Synthesis and biodistribution of 99Tcm-Cetuximab antibody for lung tumor targeted molecular imaging
Page:391—395
23. Preliminary study on effective dose of patients in SPECT/CT fusion imaging
Page:387—390
24. Clinical value of 99Tcm-MIBI scintigraphy in patients with differentiated thyroid carcinoma after surgery and first 131I therapy
Page:383—386
25. Influence of the cytosine content in liposome-coated 99Tcm-HYNIC-survivin ASODN on tumor bearing nude mice imaging
Page:355—358
26. Tumor inhibitory effects of 131I-Trastuzumab on human epidermal growth factor receptor 2 overexpressing breast cancer cells and its possible mechanisms
Page:293—297
27. 131I therapy for Graves disease: a comparative study for calculating the 131I-iodide activity based on radioactive iodine uptake formula and individualized experience method
Page:272—275
28. Impacts of infection status of hepatitis viruses and biochemical parameters of liver function on 18F-FDG uptake by the liver
Page:254—257
29. The research progress of myocardial perfusion agent with 99TcmN core
Page:237—240
30. 18F-FDG PET/CT monitoring for early tumor response to cisplatin in VX2 tumor-bearing rabbits
Page:212—216
31. The effect of P-glycoprotein on 18F-FDG uptake in tumor-bearing nude mice
Page:208—211
32. Synthesis and biodistribution of 11C-N-CH3-Dopamine as a new cardiac sympathetic nerve imaging agent
Page:204—207
33. Radionuclide pulmonary perfusion and ventilation scan in pediatric patients with bronchiolitis obliterans
Page:200—203
34. Systolic synchrony of ischemic myocardium assessed by stress-rest 99Tcm-MIBI gated SPECT myocardial perfusion imaging
Page:195—199
35. Somatostatin receptor scintigraphy of orbital inflammatory pseudotumor associated with systemic vasculitis
Page:190—194
36. Value of 18F-FDG PET/CT in patients with cancer of the uterine cervix having elevated serum squamous cell carcinoma antigen after treatment
Page:173—176
37. 18F-FDG PET/CT in evaluation of the outcome after stereotactic body radiation therapy for early-stage non-small cell lung cancer
Page:157—160
38. The effectiveness and influencing factors of 131I treatment for cervical lymph node metastases of papillary thyroid carcinoma
Page:112—115
39. Diagnostic value of 18F-FDG PET/CT in patients with pancreatic neoplasm
Page:92—96
40. Diagnostic value of 18F-FDG PET/CT in differentiating the cardiac benign from malignant lesions
Page:85—87
41. PET imaging in liver transplantation for primary hepatocarcinoma
Page:71—74
42. Targeting vulnerable plaque of experimental atherosclerosis models with 99Tcm-Duramycin
Page:53—58
43. Brain perfusion SPECT for therapeutic evaluation of patients with moyamoya disease after surgery
Page:32—35
44. Consistency of FDG uptake on 18F-FDG PET/CT and regional homogeneity on functional MRI in major depression disorder patients
Page:27—31
45. Diagnostic value of 18F-FDG PET/CT delayed imaging after diuresis in patients with primary bladder tumor
Page:10—13
46. Preparation of HER2 radioligand 99Tcm-ABH2 and its in vivo imaging in breast cancer-xenografted mice
Page:222—226
47. 18F-FDG PET/CT in evaluating the radiosensitizing effect of oleanolic acid
Page:217—221
48. Clinical value of 125I seeds implantation combined with high intensity focused ultrasound for the treatment of portal vein tumor thrombus from hepatocellular carcinoma
Page:182—185
49. Value of 18F-FDG PET/CT in the evaluation of treatment response and prognosis for patients with recurrent uterine cervical cancer
Page:168—172
50. Value of 18F-FDG PET/CT in the post-treatment evaluation of cervical cancer
Page:164—167
51. Dynamic change of peripheral blood cell in patients with differentiated thyroid cancer before and after 131I treatment
Page:116—119
52. SPECT cerebral perfusion imaging and its quantitative analysis for the assessment of stent implantation for cerebral artery stenosis
Page:108—111
53. Value of 11C-MET PET/CT in determinating conformal radiotherapeutic planning for high-grade gliomas
Page:102—107
54. Relationship between myocardial glucose metabolism in right heart and cardiac function in patients with idiopathic dilated cardiomyopathy
Page:81—84
55. Development and status of quality control and standard for nuclear medicine imaging equipment
Page:75—78
56. Application of fluorescein sodium on Cerenkov radiation energy transfer
Page:59—62
57. Relationship between the changes of biochemical markers of bone turnover and renal osteodystrophy in patients with primary nephrotic syndrome
Page:44—47
58. Evaluation of the effect of 90Sr-90Y applicator treatment for hemangioma by superficial ultrasound
Page:41—43
59. Correlation between extratemporal hypometabolism and the outcome of temporal lobectomy in patients with temporal lobe epilepsy
Page:18—21
60. 18F-FDG PET/CT imaging characteristics of Castleman's disease
Page:14—17
61. Diagnostic value of 18F-FDG PET/CT for subsolid pulmonary nodules
Page:5—9
62. Correlation between 18F-FLT PET/CT imaging and microvessel density of tumor tissue in non-small cell lung cancer
Page:1—4